ByTrending Posts
Eli Lilly Announces $6 Billion Pharmaceutical Manufacturing Campus…
Huntsville, AL – Eli Lilly and Company today announced plans to construct a $6 billion pharmaceutical manufacturing campus…
Novartis Canada Receives Positive Funding Recommendations for Scemblix®…
Montreal, QC – Novartis Canada today announced that the Institut national d’excellence en santé et en services sociaux…
Novartis Announces Agreement with U.S. Government to Support…
Basel, Switzerland – Novartis, a global leader in innovative medicines, today announced it has reached an agreement with…
Penguin AI Raises $29.7 Million to Transform Healthcare…
Palo Alto, CA Penguin AI, a healthcare technology company focused on using artificial intelligence to reduce administrative burdens,…
BioMarin Announces Agreement to Acquire Amicus Therapeutics in…
San Rafael, CA — BioMarin Pharmaceutical Inc. today announced that it has entered into a definitive agreement to…
Bristol Myers Squibb Unveils “Mosaic” AI Content Hub…
Mumbai, India Bristol Myers Squibb (BMS) today announced the launch of Mosaic, a new artificial intelligence–enabled content hub…
Endpoints Signal Report Finds Nearly Half of Biopharma…
Based on Endpoints Signal Pulse Report | December 2025 A new Signal Pulse Report from Endpoints News reveals…
Chai Discovery Becomes Newest AI Unicorn Following $130…
Company valued at $1.3 billion as investors back AI-native drug discovery platform San Francisco, California Chai Discovery today…
PhaseV Reports Breakthrough Year in 2025, Marking Transition…
Boston, Massachusetts PhaseV announced today that 2025 marked a defining year for the company, highlighted by record revenue…
Trending Posts
Latest Stories
Is Partnership-Led Innovation Replacing M&A in Oncology? BMS and Janux Strike $850 Million T-Cell Engager Deal
January 2026 Executive Summary Bristol Myers Squibb (BMS) has entered into a strategic collaboration with…
Is Partnership-Led Innovation Replacing M&A in Oncology? BMS and Janux Strike $850 Million T-Cell Engager Deal
22 January 2026 Executive Summary Bristol Myers Squibb (BMS) has entered into a strategic collaboration…
Can Global Partnerships Future-Proof Epidemic Preparedness? SK bioscience, Merck (MSD), and Hilleman Unite to Strengthen Ebola Vaccine Supply
23 January 2026 Executive Summary A global vaccine partnership has been established between SK bioscience,…
Is Strategic Out-Licensing the Fastest Path to Global Scale? Restari Secures $230 Million PDE-5 Deal with AriBio
23 January 2026 Executive Summary Restari has secured exclusive global out-licensing rights from AriBio for…
Gallery
